Market Access Solutions
At TIVMEK, we help our partners navigate the complex Canadian market access and reimbursement landscape to ensure timely and sustainable product uptake. Our team provides strategic guidance from early pricing and HEOR planning through to HTA submissions, payer negotiations, and formulary listings. We align evidence generation, stakeholder engagement, and value communication to strengthen each product’s reimbursement potential. By combining strategic insight with deep KOL and payer connectivity, TIVMEK supports partners in achieving optimized access and long-term market success
File Submission
Whether we manage the complete submission process or tailor our support to complement materials you’ve already developed, TIVMEK ensures a seamless, compliant, and efficient pathway to market access. Our team prepares and reviews all required documentation for HTA and payer submissions, ensuring alignment with clinical, economic, and real-world evidence. We also manage communication with public and private payers, address clarification requests, and help optimize submission timelines — ensuring your product reaches patients efficiently, compliantly, and with a strong value narrative.
Strategic Insights
Over the years, we’ve identified the key factors that drive success in pricing and reimbursement. At TIVMEK, we help ensure your product is well-positioned for positive listing decisions across both public and private payers by clearly demonstrating clinical and economic value. Our team effectively communicates your product’s value proposition within the framework of Canadian reimbursement and health technology assessment processes.
Advocacy
At TIVMEK, we recognize that strong physician and patient advocacy can significantly influence reimbursement outcomes and health technology assessments. We help our clients build credible, evidence-based narratives that highlight real clinical value through early engagement with key opinion leaders, medical societies, and patient advocacy groups. By aligning stakeholder perspectives and integrating real-world insights into value dossiers and submissions, we strengthen the case for access and ensure that payer evaluations reflect the true impact of your therapy on patient care.
HEOR
We integrate Health Economics and Outcomes Research (HEOR) with market access strategy to demonstrate the real-world value of your product. Our team develops robust economic models, value dossiers, and outcomes evidence to support pricing and reimbursement decisions, helping you communicate clinical and economic benefits effectively to payers and stakeholders.
Get in Touch
Montreal, QC
Canada